Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds

Gastroenterology

Volumn 124, Issue 5, 2003, Pages 1292-1299

  Rulyak, Stephen J ^a   Lowenfels, Albert B ^b   Maisonneuve, Patrick ^c   Brentnall, Teresa A ^a,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FAMILIAL CANCER; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREAS DISEASE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 0038297512     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00272-5     Document Type: Article

References (34)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Lynch HT, Smyrk T, Kern SE, Hruban RH, Lightdale CJ, Lemon SJ, Lynch JF, Fusaro LR, Fusaro RM, Ghadirian P. Familial pancreatic cancer: a review. Semin Oncol 1996;23:251-275.
3. Falk RT, Pickle LW, Fontham ET, Correa P, Fraumeni JF Jr. Lifestyle risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol 1988;18:324-336.
4. Ghadirian P, Boyle P, Simard A, Baillargeon J, Maisonneuve P, Perret C. Reported familial aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol 1991;10:183-196.
5. Fernandez E, La Vecchia C, D'Avanzo B, Negri E, Franceschi S. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 1994;3:209-212.
6. Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson GM, Schwartz AG, Brown LM, Greenberg RS, Schoenberg JB, Pottern LM, Hoover RN, Fraumeni JF Jr. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830-1837.
7. Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, Rozenblum E, Wilentz RE, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001;7:738-744.
8. Schenk M, Schwartz AG, O'Neal E, Kinnard M, Greenson JK, Fryzek JP, Ying GS, Garabrant DH. Familial risk of pancreatic cancer. J Natl Cancer Inst 2001;93:640-644.
9. Brentnall TA. Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am 2000;83:707-718.
10. Bueno de Mesquita HB, Maisonneuve P, Moerman CJ, Runia S, Boyle P. Life-time history of smoking and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer 1991;49:816-822.
11. Ghadirian P, Simard A, Baillargeon J. Tobacco, alcohol, and coffee and cancer of the pancreas: a population-based, case-control study in Quebec, Canada. Cancer 1991;67:2664-2670.
12. Howe GR, Jain M, Burch JD, Miller AB. Cigarette smoking and cancer of the pancreas: evidence for a population-based case-control study in Toronto, Canada. Int J Cancer 1991;47:323-328.
13. Silverman DT, Dunn JA, Hoover RN, Schiffman M, Lillemoe KD, Schoenberg JB, Brown LM, Greenberg RS, Hayes RB, Swanson GM, Wacholder S, Schwartz AG, Liff JM, Pottern LM. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1994;86:1510-1516.
14. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994;309:901-911.
15. Boyle P, Maisonneuve P, Bueno de Mesquita B, Ghadirian P, Howe GR, Zatonski W, Baghurst P, Moerman CJ, Simard A, Miller AB, Przewoniak K, McMichael AJ, Hsieh CC, Walker AM. Cigarette smoking and pancreas cancer: a case-control study of the search programme of the IARC. Int J Cancer 1996;67:63-71.
16. Lowenfels AB, Maisonneuve P, Whitcomb DC, Lerch MM, Di-Magno EP. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 2001;286:169-170.
17. Machlin SR, Kleinman JC, Madans JH. Validity of mortality analysis based on retrospective smoking information. Stat Med 1989;8:997-1009.
18. Hyland A, Cummings KM, Lynn WR, Corle D, Giffen CA. Effect of proxy-reported smoking status on population estimates of smoking prevalence. Am J Epidemiol 1997;145:746-751.
19. Breslow NE, Day NE. Statistical methods in cancer research. In: Analysis of case control studies. Volume 1. Lyon: IARC Sci. Publ., 1980:5-338.
20. Leder GH, Prokopczyk B, Ramadani M, Cunningham AJ, Siech M, Schwarz A, Schwarz M, Poch B, Link KH, Hoffman D, El-Bayoumy K, Beger HG. Detection of tobacco derived carcinogen in pancreatic juice of smokers - a role for the onset of pancreatic cancer. Pancreas 2001;23:448.
21. Silverman DT. Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen 2001;21:7-25.
22. Matzkin H, Soloway MS. Cigarette smoking: a review of possible associations with benign prostatic hyperplasia and prostate cancer. Prostate 1993;22:277-290.
23. Castelao JE, Yaun JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 2001;93:538-545.
24. Mooney LA PF, Van Bennekum AM, Blaner WS, Karkoszka J, Covey L, Hsu Y, Cooper TB, Frenkel K. Gender differences in autoantibodies to oxidative DNA base damage in cigarette smokers. Cancer Epidemiol Biomarkers Prev 2001;10:641-648.
25. Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001;61:3419-3424.
26. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M, Sehlub J, Virtamo J, Taylor PR. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 1999;91:535-541.
27. Cubilla AL, Fitzgerald PJ. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976;36:2690-2698.
28. DiGiuseppe JA HR, Offerhaus GJ, Clement MJ, van den Berg FM, Cameron JL, van Mansfeld AD. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994;144:889-895.
29. DiGiuseppe JA HR, Goodman SN, Polak M, van den Berg FM, Allison DC, Cameron JL, Offerhaus GJ. Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 1994;101:684-688.
30. Brat DJ LK, Yeo CJ, Warfield PB, Hruban RH. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 1998;22:163-169.
31. Ashley CT WS. Trinucleotide repeat expansion and human disease. Annu Rev Genet 1995:29:703-728.
32. Picco MF, Goodman S, Reed J, Bayless TM. Methodologic pitfalls in the determination of genetic anticipation: the case of Crohn disease. Ann Intern Med 2001;134:1124-1129.
33. Love RR EA, Josten DM. The accuracy of patient reports of a family history of cancer. J Chronic Dis 1985;38:289-293.
34. Silverman DT. Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen 2001;21:7-25.